Drug Utilization Patterns in Thyroid Disorder Patients with and without Comorbidities: A Cross-Sectional Study in the Outpatient Department of a Tertiary Care Teaching Hospital

Abstract

Thyroid dysfunction affects approximately 32% of the Indian population, making effective drug utilization crucial for optimal treatment. This study assessed drug utilization patterns in thyroid disorder patients, with and without comorbidities, at a tertiary care hospital. Data from 146 patients’ prescriptions were analyzed based on WHO prescribing indicators and checked for alignment with the National List of Essential Medicines (NLEM) 2022. Results showed 74% of patients had hypothyroidism, predominantly treated with Thyroxine, while 26% had hyperthyroidism, mainly managed with Carbimazole. Hypertension was the most common comorbidity. Findings indicate rational drug use, with most prescriptions aligning with the NLEM, supporting standardized, effective treatment in thyroid disorders.